Probing the link between oestrogen receptors and oesophageal cancer

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Rashid, Farhan ^a,b   Khan, Raheela N ^a,b   Iftikhar, Syed Y ^a,b  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PHYTOESTROGEN; RALOXIFENE; SEX HORMONE; TAMOXIFEN;

ADVANCED CANCER; APOPTOSIS; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CELL DEDIFFERENTIATION; CLINICAL ASSESSMENT; DRUG MECHANISM; EPIGENETICS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE RECEPTOR INTERACTION; HORMONE SUBSTITUTION; HUMAN; LIGAND BINDING; OSTEOPOROSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; TUMOR GROWTH; FEMALE; MALE; METABOLISM;

ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; RECEPTORS, ESTROGEN;

EID: 77949438001     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-9     Document Type: Review

References (74)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24(14):2137-50. 10.1200/JCO.2005.05.2308, 16682732.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
3. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83(10):2049-53. 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1\>3.0.CO;2-2, 9827707.
4. Armstrong RW, Borman B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. Int J Epidemiol 1996, 25(5):941-7. 10.1093/ije/25.5.941, 8921478.
5. Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999, 80(5-6):834-42. 10.1038/sj.bjc.6690429, 2362302, 10360663.
6. Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993, 54(3):402-7. 10.1002/ijc.2910540309, 8509215.
7. Gregersen LH, Friis S, Olsen JH. Cancer in esophagus and cardia--incidence trends in Denmark. Ugeskr Laeger 2008, 170(17):1460-4.
8. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009, 24(5):729-35. 10.1111/j.1440-1746.2009.05824.x, 19646015.
9. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001, 92(3):549-55. 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L, 11505399.
10. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol 2001, 30(6):1415-25. 10.1093/ije/30.6.1415, 11821356.
11. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 2008, 103(11):2694-9. 10.1111/j.1572-0241.2008.02191.x, 18853967.
12. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008, 100(16):1184-7. 10.1093/jnci/djn211, 2518165,2518165, 18695138.
13. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-6.
14. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002, 99(6):860-8. 10.1002/ijc.10427, 12115489.
15. Lambert R, Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 2007, 21(6):921-45. 10.1016/j.bpg.2007.10.001, 18070696.
16. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8(6):545-53. 10.1016/S1470-2045(07)70172-9, 17540306.
17. Hulscher JB, van Sandick JW, Tijssen JG, Obertop H, van Lanschot JJ. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 2000, 191(2):143-8. 10.1016/S1072-7515(00)00349-5, 10945357.
18. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000. 10.1097/SLA.0b013e31815c4037, 18043101.
19. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004, 99(4):582-8. 10.1111/j.1572-0241.2004.04131.x, 15089886.
20. Muir CS, McKinney PA. Cancer of the oesophagus: a global overview. Eur J Cancer Prev 1992, 1(3):259-64. 10.1097/00008469-199204000-00007, 1467771.
21. Lagergren J, Nyren O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 1998, 7(10):913-5.
22. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265(10):1287-9. 10.1001/jama.265.10.1287, 1995976.
23. Sarr MG, Hamilton SR, Marrone GC, Cameron JL. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985, 149(1):187-93. 10.1016/S0002-9610(85)80031-3, 3966636.
24. Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987, 92(1):118-24.
25. Lofdahl HE, Lu Y, Lagergren J. Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer 2008, 99(9):1506-10. 10.1038/sj.bjc.6604701, 2579703, 18841152.
26. Badwe RA, Patil PK, Bhansali MS, Mistry RC, Juvekar RR, Desai PB. Impact of age and sex on survival after curative resection for carcinoma of the esophagus. Cancer 1994, 74(9):2425-9. 10.1002/1097-0142(19941101)74:9<2425::AID-CNCR2820740906>3.0.CO;2-1, 7922995.
27. Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KE. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 2009, 58(1):16-23. 10.1136/gut.2008.161331, 18838486.
28. Molife R, Lorigan P, MacNeil S. Gender and survival in malignant tumours. Cancer Treat Rev 2001, 27(4):201-9. 10.1053/ctrv.2001.0220, 11545540.
29. Sugimachi K, Matsuoka H, Matsufuji H, Maekawa S, Kai H, Okudaira Y. Survival rates of women with carcinoma of the esophagus exceed those of men. Surg Gynecol Obstet 1987, 164(6):541-4.
30. Rashid F, Warren A, Lee AY, Lund JN, Leeder PC, Khan RN, Larvin M, Iftikhar SY. Potential significance of oestrogen receptors in oesophageal cancer. British Journal of Surgery. [Abstract] 2009, 96(S6):1-58.
31. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006, 116(3):561-70. 10.1172/JCI27987, 2373424, 16511588.
32. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93(12):5925-30. 10.1073/pnas.93.12.5925, 39164, 8650195.
33. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson JA. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997, 82(12):4258-65. 10.1210/jc.82.12.4258, 9398750.
34. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993, 17(1):263-5. 10.1006/geno.1993.1320, 8406468.
35. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392(1):49-53. 10.1016/0014-5793(96)00782-X, 8769313.
36. Delaunay F, Pettersson K, Tujague M, Gustafsson JA. Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol Pharmacol 2000, 58(3):584-90.
37. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001, 81(4):1535-65.
38. Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005, 19(8):1951-9. 10.1210/me.2004-0390, 1249516, 15705661.
39. Kalayarasan R, Ananthakrishnan N, Kate V, Basu D. Estrogen and progesterone receptors in esophageal carcinoma. Dis Esophagus 2008, 21(4):298-303. 10.1111/j.1442-2050.2007.00767.x, 18477250.
40. Tiffin N, Suvarna SK, Trudgill NJ, Riley SA. Sex hormone receptor immunohistochemistry staining in Barrett's oesophagus and adenocarcinoma. Histopathology 2003, 42(1):95-6. 10.1046/j.1365-2559.2003.01513_3.x, 12493034.
41. Awan AK, Iftikhar SY, Morris TM, Clarke PA, Grabowska AM, Waraich N, Watson SA. Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol 2007, 33(5):561-8. 10.1016/j.ejso.2006.12.001, 17254742.
42. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Harada T, Morikawa S. Effect of 17 beta-estradiol on the growth of an estrogen receptor-positive human esophageal carcinoma cell line. Cancer 1991, 67(9):2284-9. 10.1002/1097-0142(19910501)67:9<2284::AID-CNCR2820670913>3.0.CO;2-2, 2013035.
43. Tihan T, Harmon JW, Wan X, Younes Z, Nass P, Duncan KL, Duncan MD. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 2001, 21(4B):3107-14.
44. Yamashita Y, Hirai T, Mukaida H, Kawano K, Toge T, Niimoto M, Hattori T. Detection of androgen receptors in human esophageal cancer. Jpn J Surg 1989, 19(2):195-202. 10.1007/BF02471585, 2724718.
45. Tanaka S, Ueo H, Mafune K, Mori M, Wands JR, Sugimachi K. A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma. Dig Dis Sci 2001, 46(5):1016-21. 10.1023/A:1010753826788, 11341643.
46. Nozoe T, Oyama T, Takenoyama M, Hanagiri T, Sugio K, Yasumoto K. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 2007, 13(14):4046-50. 10.1158/1078-0432.CCR-07-0449, 17634528.
47. Cui G, Yuan A, Qvigstad G, Waldum HL. Estrogen receptors are not expressed in esophagogastric carcinomas that come from a high incidence area of China. Hepatogastroenterology 2001, 48(39):594-5.
48. Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M, Akiyoshi T. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 1990, 50(22):7212-5.
49. Akgun H, Lechago J, Younes M. Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer Res 2002, 22(3):1459-61.
50. Chen GG, Zeng Q, Tse GM. Estrogen and its receptors in cancer. Med Res Rev 2008, 28(6):954-74. 10.1002/med.20131, 18642351.
51. Bosetti C, Negri E, Franceschi S, Conti E, Levi F, Tomei F, La Vecchia C. Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland. Br J Cancer 2000, 82(1):204-7. 10.1054/bjoc.1999.0900, 2363177, 10638990.
52. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, . Women's Health Initiative Investigators Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004, 350(10):991-1004. 10.1056/NEJMoa032071, 14999111, Women's Health Initiative Investigators.
53. Lindblad M, Garcia Rodriguez LA, Chandanos E, Lagergren J. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006, 94(1):136-41. 10.1038/sj.bjc.6602906, 2361087, 16404367.
54. Boone J, van Hillegersberg R, Offerhaus GJ, van Diest PJ, Borel Rinkes IH, Ten Kate FJ. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis. Dis Esophagus 2009, 22(6):496-504. 10.1111/j.1442-2050.2009.00951.x, 19302210.
55. Liu L, Chirala M, Younes M. Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma. Anticancer Res 2004, 24(5A):2919-24.
56. Wang LY. Estrogen and progesterone receptors in esophageal carcinoma cells. Zhonghua Zhong Liu Za Zhi 1991, 13(1):23-5.
57. Cavallini A, Notarnicola M, Giannini R, Montemurro S, Lorusso D, Visconti A, Minervini F, Caruso MG. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer 2005, 41(10):1487-94. 10.1016/j.ejca.2005.04.008, 15949936.
58. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005, 14(1):17-21.
59. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001, 61(14):5331-5.
60. Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, Van Noorden S, Wahlström T, Warner M, Coombes RC, Gustafsson JA. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 2001, 98(26):15197-202. 10.1073/pnas.211556298, 65006, 11734621.
61. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004, 11(3):537-51. 10.1677/erc.1.00800, 2072930, 15369453.
62. Pinton G, Brunelli E, Murer B, Puntoni R, Puntoni M, Fennell DA, Gaudino G, Mutti L, Moro L. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Res 2009, 69(11):4598-604. 10.1158/0008-5472.CAN-08-4523, 19487281.
63. Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 2003, 10(2):193-202. 10.1677/erc.0.0100193, 12790782.
64. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH, Pestell RG, Kushner PJ. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002, 277(27):24353-60. 10.1074/jbc.M201829200, 11986316.
65. Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways. Mol Cell Biol 2004, 24(17):7681-94. 10.1128/MCB.24.17.7681-7694.2004, 506997, 15314175.
66. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 1999, 286(5439):481-6. 10.1126/science.286.5439.481, 10521337.
67. Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene 2003, 22(48):7600-6. 10.1038/sj.onc.1207100, 14576822.
68. Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol 2009, 307(1-2):19-24. 10.1016/j.mce.2009.03.016, 19524122.
69. Fabian CJ, Kimler BF. Selective estrogen-receptor modulators for primary prevention of breast cancer. J Clin Oncol 2005, 23(8):1644-55. 10.1200/JCO.2005.11.005, 15755972.
70. Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002, 295(5564):2465-8. 10.1126/science.1068537, 11923541.
71. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, Saag PT, Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139(10):4252-63. 10.1210/en.139.10.4252, 9751507.
72. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990, 77(8):845-57. 10.1002/bjs.1800770804, 2203505.
73. Lee PC, Port JL, Paul S, Stiles BM, Altorki NK. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Ann Thorac Surg 2009, 88(1):186-92. 10.1016/j.athoracsur.2009.03.079, 19559222.
74. Chandanos E, Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer 2009, 45(18):3149-55. 10.1016/j.ejca.2009.09.001, 19804965.